Search Details

Word: counterfuls (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

Maxine Stanley, a long-time customer, waits for her bird at the counter and remembers why she began shopping at Savenor...

Author: By Eugenia V. Levenson, CONTRIBUTING WRITER | Title: Turkey Day Brings Business to Savenor's | 11/24/1999 | See Source »

...Allen Counter, director of the Harvard Foundation for Intercultural and Race Relations, BMF President Shearwood McClelland '00 and Fletcher University Professor Cornel R. West '74 offered brief introductory remarks...

Author: By Vasugi V. Ganeshananthan, CRIMSON STAFF WRITER | Title: Sharpton Sounds Off on Racial Profiling | 11/23/1999 | See Source »

...introduction, Counter reminded his audience that Harvard hosts speakers of many viewpoints, and that the evening's discussion should remain civil...

Author: By Vasugi V. Ganeshananthan, CRIMSON STAFF WRITER | Title: Sharpton Sounds Off on Racial Profiling | 11/23/1999 | See Source »

...high-functioning individuals. Founder Ken Steele, who for 32 years wandered across America homeless and schizophrenic, feels that the most formidable task for the mentally ill is overcoming the social stigma. "The public's synonym for us is still psycho," he says. "We are feared and misunderstood." Partly to counter this, individuals with mental illness call themselves "consumers"--an emotionally neutral word meant to suggest people who consume medications and services associated with psychiatric disability. A voting effort, for example, is called a consumer-registration drive; psychosocial rehabilitation is considered consumer-driven...

Author: /time Magazine | Title: Working Their Way Back | 11/22/1999 | See Source »

...argues that additional patent years are only fair. Claritin was stuck in the Food and Drug Administration approval pipeline longer than many drugs, it claims, with the clock ticking on its 17-year patent. Schering-Plough also says Claritin profits help fund research for new drugs. But, its opponents counter, what about Claritin patients--who pay as much as $2.66 a dose instead of the 50[cents] or less they would pay, analysts figure, if a generic version of the drug were available? If the patent expires on time, according to a University of Minnesota study funded in part...

Author: /time Magazine | Title: The Claritin Case | 11/22/1999 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | Next